Millennium Management
INM icon

Millennium Management’s InMed Pharmaceuticals INM Stock Holding History

Millennium Management’s Portfolio INM Stock Details INM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-696
Closed -$91K – 6776
2022
Q3 		$91K Buy
+696
New +$129K ﹤0.01% 6000
2022
Q2 		– Sell
-28
Closed -$13K – 7209
2022
Q1 		$13K Buy
+28
New +$14.7K ﹤0.01% 6703

Other funds holding INM

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return

Millennium Management's INM Position: Q4 2022 in Review

Millennium Management sold out of InMed Pharmaceuticals (INM) in Q4 2022, closing a stake of 696 shares — an estimated $91K sold.

Millennium Management first reported a position in INM in Q1 2022 and held it in 2 quarters. The position peaked at $91K in Q3 2022. 9 funds tracked by Wall St. Rank hold INM as of Q4 2022.

  • Millennium Management reported no remaining InMed Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Millennium Management sold 696 InMed Pharmaceuticals shares in Q4 2022, an estimated $91K.
  • Millennium Management first reported a position in InMed Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • Millennium Management's InMed Pharmaceuticals position peaked at $91K in Q3 2022.
  • 9 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.